<VariationArchive VariationID="632922" VariationName="NM_001164508.2(NEB):c.3252_3255+3del" VariationType="Deletion" Accession="VCV000632922" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2019-06-03" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="621711" VariationID="632922">
      <GeneList>
        <Gene Symbol="NEB" FullName="nebulin" GeneID="4703" HGNC_ID="HGNC:7720" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151485339" stop="151734476" display_start="151485339" display_stop="151734476" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152341852" stop="152591000" display_start="152341852" display_stop="152591000" Strand="-" />
          </Location>
          <OMIM>161650</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001164508.2(NEB):c.3252_3255+3del</Name>
      <CanonicalSPDI>NC_000002.12:151679717:TACGTCA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151679718" stop="151679724" display_start="151679718" display_stop="151679724" variantLength="7" positionVCF="151679717" referenceAlleleVCF="TTACGTCA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152536232" stop="152536238" display_start="152536232" display_stop="152536238" variantLength="7" positionVCF="152536231" referenceAlleleVCF="TTACGTCA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.1" sequenceAccession="NM_001271208" sequenceVersion="1" change="c.3252_3255+3delTGACGTA">
            <Expression>NM_001271208.1:c.3252_3255+3delTGACGTA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_202" sequenceAccession="LRG_202">
            <Expression>LRG_202:g.59764_59770del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_202t1" sequenceAccession="LRG_202t1">
            <Expression>LRG_202t1:c.3252_3255+3del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.152536232_152536238del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.152536232_152536238del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.151679718_151679724del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.151679718_151679724del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009382.2" sequenceAccession="NG_009382" sequenceVersion="2" change="g.59764_59770del">
            <Expression>NG_009382.2:g.59764_59770del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004543.5" sequenceAccession="NM_004543" sequenceVersion="5" change="c.3252_3255+3del">
            <Expression>NM_004543.5:c.3252_3255+3del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164508.2" sequenceAccession="NM_001164508" sequenceVersion="2" change="c.3252_3255+3del" MANESelect="true">
            <Expression>NM_001164508.2:c.3252_3255+3del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164507.2" sequenceAccession="NM_001164507" sequenceVersion="2" change="c.3252_3255+3del" MANEPlusClinical="true">
            <Expression>NM_001164507.2:c.3252_3255+3del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.2" sequenceAccession="NM_001271208" sequenceVersion="2" change="c.3252_3255+3del">
            <Expression>NM_001271208.2:c.3252_3255+3del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.1" sequenceAccession="NM_001271208" sequenceVersion="1" change="c.3252_3255+3del">
            <Expression>NM_001271208.1:c.3252_3255+3del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1559168230" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001164508.2(NEB):c.3252_3255+3del AND Nemaline myopathy" Accession="RCV000780534" Version="1">
        <ClassifiedConditionList TraitSetID="12233">
          <ClassifiedCondition DB="MedGen" ID="C0206157">Nemaline myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-06-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.3252_3255+3del AND Nemaline myopathy 2" Accession="RCV002535675" Version="2">
        <ClassifiedConditionList TraitSetID="3882">
          <ClassifiedCondition DB="MedGen" ID="C1850569">Nemaline myopathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-14" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.3252_3255+3del AND Arthrogryposis multiplex congenita 6" Accession="RCV003467311" Version="1">
        <ClassifiedConditionList TraitSetID="66961">
          <ClassifiedCondition DB="MedGen" ID="C5543431">Arthrogryposis multiplex congenita 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-14" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-06-03" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25205138</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="66961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="56163" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Arthrogryposis multiplex congenita 6</ElementValue>
                <XRef ID="MONDO:0030281" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AMC6</ElementValue>
                <XRef Type="MIM" ID="619334" DB="OMIM" />
              </Symbol>
              <XRef ID="C5543431" DB="MedGen" />
              <XRef ID="MONDO:0030281" DB="MONDO" />
              <XRef Type="MIM" ID="619334" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3882" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5618" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy caused by mutation in the nebulin gene</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy 2</ElementValue>
                <XRef ID="Nemaline+myopathy+2/5124" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009725" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy 2, autosomal recessive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEM2</ElementValue>
                <XRef Type="MIM" ID="256030" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15209" />
                <XRef ID="15209" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22510848</ID>
              </Citation>
              <XRef ID="C1850569" DB="MedGen" />
              <XRef ID="MONDO:0009725" DB="MONDO" />
              <XRef Type="MIM" ID="256030" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12233" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9537" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Rod myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy</ElementValue>
                <XRef ID="MONDO:0018958" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS161800" DB="OMIM" />
                <XRef ID="75072002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myopathies, Nemaline</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12033" />
                <XRef ID="12033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="607" DB="Orphanet" />
              <XRef ID="C0206157" DB="MedGen" />
              <XRef ID="MONDO:0018958" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS161800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1794488" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-03" DateCreated="2019-06-03">
        <ClinVarSubmissionID localKey="NM_001271208.1:c.3252_3255+3delTGACGTA|MedGen:C0206157" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000917872" DateUpdated="2019-06-03" DateCreated="2019-06-03" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Comment>Variant summary: NEB c.3252_3255+3delTGACGTA causes the deletion of 7 nucleotides that overlap the exon/intron junction, which is predicted to result in a frameshift mutation. Several computational tools predict a significant impact on normal splicing: Five predict the variant abolishes a 5 splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 244922 control chromosomes (gnomAD). The variant, c.3252_3255+3delTGACGTA, has been reported in the literature in an individual affected with an unspecified form of NM (Lehtokari_2014). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.3252_3255+3delTGACGTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Nemaline myopathy</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0206157" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7842821" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_001271208.1:c.3252_3255+3del|OMIM:619334" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004200341" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.3252_3255+3del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619334" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6213945" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4833745|MedGen:C1850569" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003524687" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Comment>This variant results in the deletion of part of exon 32 (c.3252_3255+3del) of the NEB gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with clinical features of nemaline myopathy (PMID: 25205138; Invitae). ClinVar contains an entry for this variant (Variation ID: 632922). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.152536232_152536238del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1850569" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1794488" TraitType="Disease" MappingType="Name" MappingValue="Nemaline myopathy" MappingRef="Preferred">
        <MedGen CUI="C0206157" Name="Nemaline myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6213945" TraitType="Disease" MappingType="XRef" MappingValue="C1850569" MappingRef="MedGen">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7842821" TraitType="Disease" MappingType="XRef" MappingValue="619334" MappingRef="OMIM">
        <MedGen CUI="C5543431" Name="Arthrogryposis multiplex congenita 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

